Wikidata

(Q61936306)

English

A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.

clinical trial

In more languages

Statements

title
A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Sitagliptin in Subjects With Type 2 Diabetes Mellitus With Renal Impairment (English)
0 references
sponsor
GSK
0 references
country
Australia
0 references
Brazil
0 references
Colombia
0 references
Germany
0 references
India
0 references
Israel
0 references
Peru
0 references
Philippines
0 references
South Africa
0 references
Spain
0 references
Taiwan
0 references
United Kingdom
0 references
start time
May 2010
0 references
end time
November 2012
0 references
number of participants
507
0 references
research site
GSK
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61936306&oldid=2131970658"